Jake Jorgovan

MAY 20, 2024

Premier Consulting : Premier Consulting provides strategic product development and regulatory consulting services to emerging biotech and specialty pharma companies, guiding them from early-stage planning to commercialization. BioPharmGuy BioPharmGuy is a comprehensive directory featuring over 428 biotech consulting companies worldwide.

Biopharma 130

Biopharma Biotech Life science Partnering capability and readiness 130

Jake Jorgovan

JUNE 3, 2024

Premier Consulting: Premier Consulting is a strategic consulting firm focused on aiding biotech and specialty pharma companies through complex drug development processes, from strategy to commercialization. Premier Consulting combines deep regulatory expertise with a comprehensive understanding of the biotech industry's unique challenges.

Biopharma 130

Biopharma Biotech Biopharmaceuticals Life science 130

Jake Jorgovan

NOVEMBER 29, 2023

BioPharma Consultants : Specializes in marketing, strategy, and corporate development services for the biotech and pharmaceutical industries, offering solutions from product launch plans to commercial support for fundraising.

Biopharmaceuticals 130

Biopharmaceuticals Biopharma Biotech Life science 130

Jake Jorgovan

FEBRUARY 19, 2024

Their approach often emphasizes due diligence, strategic planning, and seamless integration to maximize value creation. Alacrita Alacrita is a consultancy firm in the pharmaceutical and biotech industries, specializing in comprehensive due diligence services.

Biotech 130

Biotech Value creation Law firms Credit 130

Jake Jorgovan

FEBRUARY 1, 2024

Herspiegel Consulting : Recognized for its excellence in commercial strategy, Herspiegel Consulting focuses on innovative solutions for pharmaceutical and biotech companies, with a strong track record in product launches and commercial execution. Assisting in capturing opportunities across the value chain. market goals for its clients.

Life science 130

Life science Biotech Biotechnology Engineering 130

LaVoie Health Science Blog

JULY 1, 2020

As biotech and pharmaceutical companies work to stabilize their clinical programs and business strategies during the significant disruptions caused by the COVID-19 pandemic, one of the potential challenges that public companies may encounter is aggressive moves by activist investors looking to leverage the economic turmoil for corporate takeovers.

Biotech 52

Biotech Life science Biopharma Value creation 52

LaVoie Health Science Blog

JULY 16, 2021

As investments into sustainable companies and funds have surged to new highs, how can biotech and life science companies best position themselves with this burgeoning group of investors. Are there investment/business risks in not pursuing an ESG reporting approach? However, it has it unique characteristics to address from an ESG standpoint.

Life science 69

Life science Biopharma Biotech Biotechnology 69